Literature DB >> 15013447

Suppression of Epstein-Barr virus-encoded latent membrane protein-1 by RNA interference inhibits the metastatic potential of nasopharyngeal carcinoma cells.

Xiang-Ping Li1, Gang Li, Ying Peng, Hsiang-fu Kung, Marie C Lin.   

Abstract

Nasopharyngeal carcinoma (NPC) is a highly metastatic tumor characterized by close association with EBV. Of the EBV-encoded products, latent membrane protein-1 (LMP-1) is thought to be the only oncoprotein playing an essential role in cell transformation as well as tumor metastasis. In this study, we tested the effect of suppressing LMP-1 by RNA interference (RNAi) on the proliferative and metastatic potentials of an EBV-positive NPC cell line, C666. We showed that stably suppressing LMP-1 by short hairpin RNA (shRNA) plasmid significantly altered cell motility, substratum adhesion, and transmembrane invasion ability. However, it has little effect on the rate of cell growth and cell cycle control. These results demonstrated the effectiveness of RNAi in suppressing LMP-1, supporting an important role of LMP-1 in NPC metastasis, and suggested a potential application of RNAi-mediated therapeutic strategy for EBV-related NPC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15013447     DOI: 10.1016/j.bbrc.2004.01.045

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Infection of Epstein-Barr virus in a gastric carcinoma cell line induces anchorage independence and global changes in gene expression.

Authors:  Aron R Marquitz; Anuja Mathur; Kathy H Y Shair; Nancy Raab-Traub
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-30       Impact factor: 11.205

Review 2.  Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.

Authors:  Abhik Saha; Erle S Robertson
Journal:  Clin Cancer Res       Date:  2011-03-03       Impact factor: 12.531

3.  Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt's lymphoma cells.

Authors:  Mei Hong; Yoshihiro Murai; Tomohiko Kutsuna; Hiroyuki Takahashi; Kazuhiro Nomoto; Chun-Mei Cheng; Shin Ishizawa; Qing-Li Zhao; Ryohei Ogawa; Brian V Harmon; Koichi Tsuneyama; Yasuo Takano
Journal:  J Cancer Res Clin Oncol       Date:  2005-09-23       Impact factor: 4.553

4.  The interactome of EBV LMP1 evaluated by proximity-based BioID approach.

Authors:  Mark A Rider; Mujeeb R Cheerathodi; Stephanie N Hurwitz; Dingani Nkosi; Lauren A Howell; Deanna C Tremblay; Xia Liu; Fanxiu Zhu; David G Meckes
Journal:  Virology       Date:  2018-01-09       Impact factor: 3.616

5.  EBV-LMP1-targeted DNAzyme restrains nasopharyngeal carcinoma growth in a mouse C666-1 xenograft model.

Authors:  Xia Ke; Yu-cheng Yang; Su-ling Hong
Journal:  Med Oncol       Date:  2010-09-24       Impact factor: 3.064

6.  siRNA-participated chemotherapy: an efficient and specific therapeutic against gastric cancer.

Authors:  Donglei Zhou; Xun Jiang; Weixing Ding; Lijun Zheng; Lei Yang; Chengzhu Zheng; Liesheng Lu
Journal:  J Cancer Res Clin Oncol       Date:  2013-09-28       Impact factor: 4.553

7.  Targeted gene therapy of nasopharyngeal cancer in vitro and in vivo by enhanced thymidine kinase expression driven by human TERT promoter and CMV enhancer.

Authors:  Cong-Xiang Shen; Zhong Wen; Yu-Hong Qian; Shao-Feng Mu; Xiao-Fang Guan
Journal:  J Exp Clin Cancer Res       Date:  2010-07-13

8.  Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome.

Authors:  Na Wang; Qiu-Liang Wu; Yan Fang; Hai-Qiang Mai; Mu-Sheng Zeng; Guo-Ping Shen; Jing-Hui Hou; Yi-Xin Zeng
Journal:  J Transl Med       Date:  2005-06-26       Impact factor: 5.531

Review 9.  Cancer stem-like cells in Epstein-Barr virus-associated nasopharyngeal carcinoma.

Authors:  Samantha Wei-Man Lun; Siu-Tim Cheung; Kwok-Wai Lo
Journal:  Chin J Cancer       Date:  2014-09-16

10.  Downregulation of ATOH8 induced by EBV-encoded LMP1 contributes to the malignant phenotype of nasopharyngeal carcinoma.

Authors:  Zifeng Wang; Jiajun Xie; Min Yan; Jing Wang; Xi Wang; Jialiang Zhang; Yan Zhang; Pengfei Li; Xinxing Lei; Qitao Huang; Suxia Lin; Xiang Guo; Quentin Liu
Journal:  Oncotarget       Date:  2016-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.